Cyclosporine pharmacokinetics in stable renal transplant recipients after Neoral conversion.

被引:0
|
作者
Pescovitz, MD [1 ]
机构
[1] INDIANA UNIV, INDIANAPOLIS, IN 46204 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A3361 / A3361
页数:1
相关论文
共 50 条
  • [21] Neoral-to-Gengraf conversion in renal transplant recipients
    Carnahan, W
    Cooper, TY
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1308 - 1313
  • [22] COMPARISON OF THE PHARMACOKINETICS OF CYCLOSPORINE SANDIMMUNE WITH SANDIMMUNE-NEORAL IN STABLE RENAL-TRANSPLANT PATIENTS
    SKETRIS, IS
    LAWEN, JG
    BEAUREGARDZOLLINGER, L
    BELITSKY, P
    LANDSBERG, D
    GIVNER, ML
    KEOWN, P
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2961 - 2963
  • [23] The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function
    Qazi, Yasir A.
    Forrest, Alan
    Tornatore, Kathleen
    Venuto, Rocco C.
    CLINICAL TRANSPLANTATION, 2006, 20 (03) : 313 - 317
  • [24] Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery
    Banner, NR
    David, OJ
    Leaver, N
    Davis, J
    Breen, J
    Johnston, A
    Yacoub, MH
    TRANSPLANT INTERNATIONAL, 2002, 15 (12) : 649 - 654
  • [25] Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients
    Baid-Agrawal, S
    Delmonico, FL
    Tolkoff-Rubin, NE
    Farrell, M
    Williams, WW
    Shih, V
    Auchincloss, H
    Cosimi, AB
    Pascual, M
    TRANSPLANTATION, 2004, 77 (08) : 1199 - 1202
  • [26] Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
    Thervet, E
    Morelon, E
    Ducloux, D
    Bererhi, L
    Noël, LH
    Bedrossian, JJ
    Puget, S
    Chalopin, JM
    Mihatsch, M
    Legendre, C
    Kreis, H
    CLINICAL TRANSPLANTATION, 2000, 14 (06) : 561 - 566
  • [27] Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral
    Mendez, R
    Abboud, H
    Burdick, J
    Copley, B
    Freeman, R
    Batiuk, TD
    Cooney, GF
    Barbeito, R
    CLINICAL THERAPEUTICS, 1999, 21 (01) : 160 - 171
  • [28] Neoral pharmacokinetics in Latino and Caucasian pediatric renal transplant recipients
    J. Lemire
    Edmund V. Capparelli
    Nadine Benador
    Paul Grimm
    Dina Macdonald
    Vivian Reznik
    Pediatric Nephrology, 2001, 16 : 311 - 314
  • [29] Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: Results from a single center
    Cossu, M
    Satta, R
    Branca, GF
    Pala, PG
    Serra, G
    Satta, RP
    Sorba, G
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1762 - 1763
  • [30] Conversion from sandimmune to neoral in stable heart transplant recipients
    Pethig, K
    Ruhparwar, A
    Korn, A
    Christians, U
    Wahlers, T
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2287 - 2289